Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study to Evaluate the Persistence and Characteristics of Humoral and Cellular Immunity Against SARS-COV-2 After Vaccination in HIV-infected Patients Severely Immunosuppressed

NCT05633927 is registered in ClinicalTrials.gov with Hospitales Universitarios Virgen del Rocío as lead sponsor.

NCT NCT05633927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05633927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study to Evaluate the Persistence and Characteristics of Humoral and Cellular Immunity Against SARS-COV-2 After Vaccination in HIV-infected Patients Severely Immunosuppressed
Lead sponsor
Hospitales Universitarios Virgen del Rocío
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
December 1, 2022
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, sars-cov-2 rna vaccines